Shots:Priya spoke about the study design and key findings from the P-II (LILAC), P-III (TOPAZ-1) & (TOPAZ-2) clinical study evaluating litifilimabShe also talked about the P-III trial evaluating Dapirolizumab pegol in collaboration with UCB to treat SLEThe interview summarizes how Biogen’s innovative medications are helping patients with Systemic Lupus Erythematosus which has…
